Bhavna Murali, Q. R. (2018). Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss. The American Association for Cancer Research (AACR).
Chicago Style (17th ed.) CitationBhavna Murali, Qihao Ren. Inhibition of the Stromal P38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss. The American Association for Cancer Research (AACR), 2018.
MLA (9th ed.) CitationBhavna Murali, Qihao Ren. Inhibition of the Stromal P38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss. The American Association for Cancer Research (AACR), 2018.
Warning: These citations may not always be 100% accurate.